Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 9
Submit an article Journal homepage
616
Views
1
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Mohamad Bassam SonbolDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Talal HilalDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Amylou C. DueckSection of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA; View further author information
,
Allison C. RosenthalDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Christopher R. ConleyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA; View further author information
,
Heidi E. KosiorekSection of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA; View further author information
,
Brenda F. GinosSection of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA; View further author information
,
Katherine M. GanoCancer Clinical Research Office, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Craig S. NicholsDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Jose F. LeisDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Patrick B. JohnstonDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Thomas M. HabermannDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Donald W. NorthfeltDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
Peter Leif BergsagelDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; View further author information
,
David J. InwardsDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Thomas E. WitzigDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
,
Stephen M. AnsellDivision of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
&
Craig B. ReederDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; Correspondence[email protected]
View further author information
 show all
Pages 2128-2134 | Received 02 Nov 2017, Accepted 03 Dec 2017, Published online: 10 Jan 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.